Skip to main content
Top
Published in: Clinical Rheumatology 6/2018

01-06-2018 | Original Article

Aortic, carotid intima-media thickness and flow- mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseases

Authors: Emanuela Del Giudice, Anna Dilillo, Luciana Tromba, Giuseppe La Torre, Sara Blasi, Fabrizio Conti, Franca Viola, Salvatore Cucchiara, Marzia Duse

Published in: Clinical Rheumatology | Issue 6/2018

Login to get access

Abstract

The aims of this study were to identify the presence of endothelial dysfunction as a marker of early atherosclerosis by measuring aortic and carotid intimal-medial thickness (aIMT and cIMT) and flow-mediated dilation (FMD) and their correlation with traditional and no traditional risk factors for atherosclerosis in children with rheumatic diseases. Thirty-nine patients (mean age 15.3 ± 5.7 years), 23 juvenile idiopathic arthritis, 9 juvenile spondyloarthropathies, 7 connective tissue diseases (mean disease duration and onset respectively 5 ± 3.6 and 10 ± 5 years), and 52 healthy children matched for sex and age were enrolled. Demographic data (age, sex, familiarity for cardiovascular disease), traditional risk factors for atherosclerosis (BMI, active and passive smoking, dyslipidemia), activity disease indexes (reactive count protein, erythrocyte sedimentation rate) autoantibodies, and complement tests were collected. aIMT, cIMT, and FMD were assessed following a standardized protocol by high-resolution ultrasonography. Patients resulted significantly more exposed to passive smoking and had a lower BMI and higher homocysteine level than controls. cIMT and aIMT were significantly higher in patients than controls (p < 0.001) and correlated with age at diagnosis (p < 0.001 r 0.516 and 0.706, respectively) but not with mean disease duration. FMD % was significantly reduced in patients compared to controls (p < 0.001). Subclinical atherosclerosis occurs in pediatric rheumatic diseases, mainly in early onset forms, and aIMT is an earlier marker of preclinical atherosclerosis. Premature endothelial dysfunction could be included in the follow-up of children with rheumatic disorders to plan prevention strategies of cardiovascular disease already in pediatrics.
Literature
1.
go back to reference WHO (2014) Global health estimates: death by cause, age, sex and country, 2000–2012. WHO, Geneva WHO (2014) Global health estimates: death by cause, age, sex and country, 2000–2012. WHO, Geneva
3.
go back to reference Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2006) Inflammation and endothelial dysfunction in rheumatoid arthritis. Clin Exp Rheumatol 24:115–117PubMed Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2006) Inflammation and endothelial dysfunction in rheumatoid arthritis. Clin Exp Rheumatol 24:115–117PubMed
4.
go back to reference Satija M, Yadav TP, Sachdev N et al (2014) Endothelial function, arterial wall mechanics and intima media thickness in juvenile idiopathic arthritis. Clin Exp Rheumatol 32:432–439PubMed Satija M, Yadav TP, Sachdev N et al (2014) Endothelial function, arterial wall mechanics and intima media thickness in juvenile idiopathic arthritis. Clin Exp Rheumatol 32:432–439PubMed
5.
go back to reference Vincze M, Dér H, Kerekes G et al (2014) Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients. Clin Rheumatol 33:1635–1641. doi:10.1007/s10067-014-2561-y CrossRefPubMed Vincze M, Dér H, Kerekes G et al (2014) Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients. Clin Rheumatol 33:1635–1641. doi:10.​1007/​s10067-014-2561-y CrossRefPubMed
7.
go back to reference Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P; International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392 Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P; International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392
9.
go back to reference Petty R, Laxer R, Lindsey C, Wedderburn L (2016) Textbook of pediatric rheumatology Petty R, Laxer R, Lindsey C, Wedderburn L (2016) Textbook of pediatric rheumatology
10.
go back to reference Chambless LE, Heiss G, Folsom AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 146:483–494. doi:10.1093/oxfordjournals.aje.a009302 Chambless LE, Heiss G, Folsom AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol 146:483–494. doi:10.​1093/​oxfordjournals.​aje.​a009302
14.
go back to reference Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task force. J am Coll Cardiol 39:257–265CrossRefPubMed Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task force. J am Coll Cardiol 39:257–265CrossRefPubMed
16.
go back to reference Mahajan V, Handa R, Kumar U et al (2008) Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. J Assoc Physicians India 56:587–590 Mahajan V, Handa R, Kumar U et al (2008) Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. J Assoc Physicians India 56:587–590
17.
go back to reference Vlahos AP, Theocharis P, Bechlioulis A et al (2011) Changes in vascular function and structure in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63:1736–1744. doi:10.1002/acr.20613 Vlahos AP, Theocharis P, Bechlioulis A et al (2011) Changes in vascular function and structure in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63:1736–1744. doi:10.​1002/​acr.​20613
18.
go back to reference Evensen K, Aulie HA, Rønning OM et al (2016) Carotid atherosclerosis in adult patients with persistently active juvenile idiopathic arthritis compared with healthy controls carotid atherosclerosis in adult patients with persistently active juvenile idiopathic arthritis compared with healthy controls. J Rheumatol. 43(4):810–5. https://doi.org/10.3899/jrheum.150499 Evensen K, Aulie HA, Rønning OM et al (2016) Carotid atherosclerosis in adult patients with persistently active juvenile idiopathic arthritis compared with healthy controls carotid atherosclerosis in adult patients with persistently active juvenile idiopathic arthritis compared with healthy controls. J Rheumatol. 43(4):810–5. https://​doi.​org/​10.​3899/​jrheum.​150499
19.
go back to reference Breda L, Di Marzio D, Giannini C et al (2013) Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis. Clin Res Cardiol 102:63–71. doi:10.1007/s00392-012-0496-3 Breda L, Di Marzio D, Giannini C et al (2013) Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis. Clin Res Cardiol 102:63–71. doi:10.​1007/​s00392-012-0496-3
20.
go back to reference Pietrewicz E, Urban M (2007) Early atherosclerosis changes in children with juvenile idiopathic arthritis. Pol Merkur Lek 22:211–214 Pietrewicz E, Urban M (2007) Early atherosclerosis changes in children with juvenile idiopathic arthritis. Pol Merkur Lek 22:211–214
21.
go back to reference Soltész P, Dér H, Kerekes G (2009) A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases. Clin Rheumatol 28:655–662. doi:10.1007/s10067-009-1118-y Soltész P, Dér H, Kerekes G (2009) A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases. Clin Rheumatol 28:655–662. doi:10.​1007/​s10067-009-1118-y
22.
go back to reference Urbina EM, Williams RV, Alpert BS et al (2009) Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the american heart association. Hypertension 54:919–950. doi:10.1161/HYPERTENSIONAHA.109.192639 Urbina EM, Williams RV, Alpert BS et al (2009) Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the american heart association. Hypertension 54:919–950. doi:10.​1161/​HYPERTENSIONAHA.​109.​192639
23.
go back to reference Lim TK, Lim E, Dwivedi G, Kooner J, Senior R (2008) Normal value of carotid intima-media thickness—a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J am Soc Echocardiogr 21:112–116 Lim TK, Lim E, Dwivedi G, Kooner J, Senior R (2008) Normal value of carotid intima-media thickness—a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J am Soc Echocardiogr 21:112–116
24.
go back to reference Consolaro A, Ruperto N, Bazso A et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61:658–666. doi:10.1002/art.24516 Consolaro A, Ruperto N, Bazso A et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61:658–666. doi:10.​1002/​art.​24516
25.
go back to reference Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med Apr 21:1685–1695CrossRef Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med Apr 21:1685–1695CrossRef
26.
go back to reference Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46:862–873 Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46:862–873
27.
go back to reference Van Halm VP, Nurmohamed MT, Twisk JW et al (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8:R151. doi:10.1186/ar2045 Van Halm VP, Nurmohamed MT, Twisk JW et al (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8:R151. doi:10.​1186/​ar2045
28.
go back to reference Dixon WG, Watson KD, Lunt M et al (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56:2905–2912. doi:10.1002/art.22809 Dixon WG, Watson KD, Lunt M et al (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56:2905–2912. doi:10.​1002/​art.​22809
31.
go back to reference Guin A, Chatterjee Adhikari M, Chakraborty S et al (2013) Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study. Semin Arthritis Rheum 43:48–54. doi:10.1016/j.semarthrit.2012.12.027 CrossRefPubMed Guin A, Chatterjee Adhikari M, Chakraborty S et al (2013) Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study. Semin Arthritis Rheum 43:48–54. doi:10.​1016/​j.​semarthrit.​2012.​12.​027 CrossRefPubMed
Metadata
Title
Aortic, carotid intima-media thickness and flow- mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseases
Authors
Emanuela Del Giudice
Anna Dilillo
Luciana Tromba
Giuseppe La Torre
Sara Blasi
Fabrizio Conti
Franca Viola
Salvatore Cucchiara
Marzia Duse
Publication date
01-06-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 6/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3705-7

Other articles of this Issue 6/2018

Clinical Rheumatology 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.